{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:53:05Z","timestamp":1761918785847},"reference-count":37,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2006,3,2]],"date-time":"2006-03-02T00:00:00Z","timestamp":1141257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> The pathogenetic mechanisms of hepatic encephalopathy (HE) are not fully understood. Cerebral blood flow regulated by cyclooxygenase (COX) may be involved in the development of HE. There are no comprehensive data concerning the effects of COX inhibition on HE in chronic liver disease.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Male Sprague\u2013Dawley rats weighing 240\u2013270\u2003g at the time of surgery were selected for experiments. Secondary biliary cirrhosis was induced by bile duct ligation (BDL). Those rats were then divided into two groups to receive i.p. injection of indomethacin (5\u2003mg\/kg per day) or distilled water for 7\u2003days from day 36 to day 42 after BDL. The control group consisted of rats receiving a sham operation. Severity of encephalopathy was assessed by counts of motor activity. Plasma levels of tumor necrosis factor (TNF)\u2010\u03b1 and 6\u2010keto\u2010prostaglandin <jats:italic>F<\/jats:italic><jats:sub>1\u03b1<\/jats:sub> (6\u2010keto\u2010PGF<jats:sub>1\u03b1<\/jats:sub>), and liver biochemistry tests were determined after treatment.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The motor activity in both groups of BDL rats were significantly lower than that of the control group (<jats:italic>P<\/jats:italic>\u2003&lt; 0.001). As compared with the BDL rats treated with distilled water, BDL rats treated with indomethacin had significant lower levels of 6\u2010keto\u2010PGF<jats:sub>1\u03b1<\/jats:sub>, but the motor activity, TNF\u2010\u03b1 levels and serum biochemistry tests were not significantly different between both BDL groups.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Chronic indomethacin administration did not have significantly detrimental or therapeutic effects on the severity of encephalopathy in BDL rats.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2006.04261.x","type":"journal-article","created":{"date-parts":[[2006,3,2]],"date-time":"2006-03-02T17:09:16Z","timestamp":1141319356000},"page":"1483-1487","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lack of detrimental or therapeutic effects of cyclooxygenase inhibition in bile duct\u2010ligated rats with hepatic encephalopathy"],"prefix":"10.1111","volume":"21","author":[{"given":"Cho\u2010Yu","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa\u2010Yauh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teh\u2010Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seng\u2010Wong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Full\u2010Young","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei\u2010Hwa","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u2010Chou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun\u2010Sang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui\u2010Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou\u2010Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30639-3"},{"key":"e_1_2_6_3_2","first-page":"245","article-title":"Fulminant hepatic failure","volume":"38","author":"Sherlock S","year":"1993","journal-title":"Adv. Intern. Med."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-206-43770"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200538"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91451-9"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840170116"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198903000-00012"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(85)90503-7"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2001.00775.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i2.232"},{"key":"e_1_2_6_12_2","first-page":"281","article-title":"Hypothalamic, striatal and plasma leucine enkephalin level in two rat models of portal hypertension","volume":"45","author":"Klin MJ","year":"1993","journal-title":"Pol. J. Pharmacol."},{"key":"e_1_2_6_13_2","first-page":"373","article-title":"The effect of (a) neomycin and lactulose treatment on systemic and portal serum GABA levels in rats and (b) pH changes on [3H] GABA binding to isolated rat hepatocytes","volume":"11","author":"Minuk GY","year":"1988","journal-title":"Clin. Invest. Med."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01295.x"},{"key":"e_1_2_6_15_2","first-page":"305","article-title":"Prolonged bile duct ligation obstruction: a new experimental model of cirrhosis in the rat","volume":"65","author":"Kountouras J","year":"1984","journal-title":"Br. J. Exp. Pathol."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0680023"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180224"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310306"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840140602"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(85)90037-8"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.116.161"},{"key":"e_1_2_6_22_2","first-page":"263","article-title":"Establishment of an animal model of hepatic encephalopathy","volume":"63","author":"Chu CJ","year":"2000","journal-title":"J. Chin. Med. Assoc."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80361-4"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80110-5"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021989230535"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-42644"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1991.67"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.75.3.528"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0361-9230(98)00052-5"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.1997.14.637"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.26383"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(81)80049-2"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080210"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90105-8"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114268"},{"key":"e_1_2_6_36_2","first-page":"88A","article-title":"A randomized controlled trial of prostaglandin E2 in the treatment of fulminant hepatic failure","volume":"16","author":"Sheener P","year":"1992","journal-title":"Hepatology"},{"key":"e_1_2_6_37_2","first-page":"A862","article-title":"Prostaglandin E1 infusion is effective in the late treatment of patients with acetaminophen induced acute hepatic failure referred for liver transplantation","volume":"102","author":"O\u2019Brien CB","year":"1992","journal-title":"Gastroenterology"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613060"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2006.04261.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2006.04261.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T10:38:25Z","timestamp":1697366305000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2006.04261.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,28]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1111\/j.1440-1746.2006.04261.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04261.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,28]]},"assertion":[{"value":"2006-07-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}